Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma

about

Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma

Item

http://www.wikidata.org/entity/Q61865057

description

clinical trial

@en

klinisch onderzoek

@nl

name

Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma

@en

type

Item

label

Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma

@en

prefLabel

Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma

@en

P1476

Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma

@en

P17

Ameeriga Ütisriigiq

P3098

NCT00942877

http://www.w3.org/2001/XMLSchema#string

P31

clinical trial

P4135

http://www.w3.org/2001/XMLSchema#decimal

P4844

cediranib

P580

2009-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P582

2020-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6099

phase II clinical trial

P6153

National Institutes of Health

P8363

interventional study

P859

National Cancer Institute

Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma

about

Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma

description

name

type

label

prefLabel

P1050

P1132

P1476

P17

P3098

P31

P4135

P4844

P580

P582

P6099

P6153

P8363

P859

P1050

P1132

P1476

P17

P3098

P31

P4135

P4844

P580

P582

P6099

P6153

P8363

P859